nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ORM1—bile—gallbladder cancer	0.0378	0.106	CbGeAlD
Imatinib—CA9—gall bladder—gallbladder cancer	0.0179	0.0503	CbGeAlD
Imatinib—DDR1—pancreas—gallbladder cancer	0.0146	0.041	CbGeAlD
Imatinib—PDGFRA—gall bladder—gallbladder cancer	0.0143	0.0403	CbGeAlD
Imatinib—KIT—gall bladder—gallbladder cancer	0.0114	0.0322	CbGeAlD
Imatinib—PDGFRB—gall bladder—gallbladder cancer	0.0112	0.0314	CbGeAlD
Imatinib—ORM1—gall bladder—gallbladder cancer	0.0105	0.0295	CbGeAlD
Imatinib—DDR1—liver—gallbladder cancer	0.00928	0.0261	CbGeAlD
Imatinib—ALB—gall bladder—gallbladder cancer	0.00919	0.0259	CbGeAlD
Imatinib—PIP4K2C—pancreas—gallbladder cancer	0.009	0.0253	CbGeAlD
Imatinib—ABCA3—lymph node—gallbladder cancer	0.00771	0.0217	CbGeAlD
Imatinib—DDR1—lymph node—gallbladder cancer	0.00711	0.02	CbGeAlD
Imatinib—CA2—gall bladder—gallbladder cancer	0.00678	0.0191	CbGeAlD
Imatinib—NQO2—pancreas—gallbladder cancer	0.00661	0.0186	CbGeAlD
Imatinib—ABL2—liver—gallbladder cancer	0.00605	0.017	CbGeAlD
Imatinib—KIT—epithelium—gallbladder cancer	0.00592	0.0167	CbGeAlD
Imatinib—PDGFRB—epithelium—gallbladder cancer	0.00578	0.0163	CbGeAlD
Imatinib—PIP4K2C—liver—gallbladder cancer	0.00573	0.0161	CbGeAlD
Imatinib—CA3—liver—gallbladder cancer	0.00547	0.0154	CbGeAlD
Imatinib—KIT—pancreas—gallbladder cancer	0.00527	0.0148	CbGeAlD
Imatinib—PDGFRB—pancreas—gallbladder cancer	0.00515	0.0145	CbGeAlD
Imatinib—LCK—liver—gallbladder cancer	0.00508	0.0143	CbGeAlD
Imatinib—CA14—liver—gallbladder cancer	0.00496	0.014	CbGeAlD
Imatinib—CYP3A7—liver—gallbladder cancer	0.00486	0.0137	CbGeAlD
Imatinib—CA1—pancreas—gallbladder cancer	0.00482	0.0136	CbGeAlD
Imatinib—ABL2—lymph node—gallbladder cancer	0.00464	0.0131	CbGeAlD
Imatinib—ABL1—pancreas—gallbladder cancer	0.00459	0.0129	CbGeAlD
Imatinib—PIP4K2C—lymph node—gallbladder cancer	0.00439	0.0124	CbGeAlD
Imatinib—NQO2—liver—gallbladder cancer	0.00421	0.0118	CbGeAlD
Imatinib—PDGFRA—liver—gallbladder cancer	0.00419	0.0118	CbGeAlD
Imatinib—CA3—lymph node—gallbladder cancer	0.00419	0.0118	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—liver—gallbladder cancer	0.00413	0.0116	CbGeAlD
Imatinib—LCK—lymph node—gallbladder cancer	0.0039	0.011	CbGeAlD
Imatinib—CSF1R—liver—gallbladder cancer	0.00369	0.0104	CbGeAlD
Imatinib—CA2—epithelium—gallbladder cancer	0.00351	0.00987	CbGeAlD
Imatinib—SLC47A1—liver—gallbladder cancer	0.00337	0.00949	CbGeAlD
Imatinib—KIT—liver—gallbladder cancer	0.00335	0.00944	CbGeAlD
Imatinib—PDGFRB—liver—gallbladder cancer	0.00328	0.00922	CbGeAlD
Imatinib—NQO2—lymph node—gallbladder cancer	0.00322	0.00908	CbGeAlD
Imatinib—PDGFRA—lymph node—gallbladder cancer	0.00322	0.00905	CbGeAlD
Imatinib—CA2—pancreas—gallbladder cancer	0.00312	0.00879	CbGeAlD
Imatinib—ORM1—liver—gallbladder cancer	0.00307	0.00865	CbGeAlD
Imatinib—CA1—liver—gallbladder cancer	0.00307	0.00863	CbGeAlD
Imatinib—ABL1—liver—gallbladder cancer	0.00292	0.00822	CbGeAlD
Imatinib—CSF1R—lymph node—gallbladder cancer	0.00283	0.00797	CbGeAlD
Imatinib—SLC22A1—liver—gallbladder cancer	0.00281	0.00792	CbGeAlD
Imatinib—PTGS1—epithelium—gallbladder cancer	0.00271	0.00763	CbGeAlD
Imatinib—ALB—liver—gallbladder cancer	0.00269	0.00758	CbGeAlD
Imatinib—CYP3A5—pancreas—gallbladder cancer	0.00269	0.00756	CbGeAlD
Imatinib—SLC47A1—lymph node—gallbladder cancer	0.00259	0.00728	CbGeAlD
Imatinib—KIT—lymph node—gallbladder cancer	0.00257	0.00724	CbGeAlD
Imatinib—PDGFRB—lymph node—gallbladder cancer	0.00251	0.00707	CbGeAlD
Imatinib—ORM1—lymph node—gallbladder cancer	0.00236	0.00663	CbGeAlD
Imatinib—CA1—lymph node—gallbladder cancer	0.00235	0.00662	CbGeAlD
Imatinib—ABL1—lymph node—gallbladder cancer	0.00224	0.0063	CbGeAlD
Imatinib—CYP2C19—liver—gallbladder cancer	0.00217	0.00611	CbGeAlD
Imatinib—ALB—lymph node—gallbladder cancer	0.00207	0.00581	CbGeAlD
Imatinib—CA2—liver—gallbladder cancer	0.00199	0.0056	CbGeAlD
Imatinib—ABCG2—liver—gallbladder cancer	0.00184	0.00518	CbGeAlD
Imatinib—CYP1A2—liver—gallbladder cancer	0.00177	0.00499	CbGeAlD
Imatinib—CYP3A5—liver—gallbladder cancer	0.00171	0.00481	CbGeAlD
Imatinib—CYP2C9—liver—gallbladder cancer	0.00168	0.00473	CbGeAlD
Imatinib—ABCB1—epithelium—gallbladder cancer	0.0016	0.00451	CbGeAlD
Imatinib—CA2—lymph node—gallbladder cancer	0.00152	0.00429	CbGeAlD
Imatinib—ABCB1—pancreas—gallbladder cancer	0.00143	0.00402	CbGeAlD
Imatinib—ABCG2—lymph node—gallbladder cancer	0.00141	0.00397	CbGeAlD
Imatinib—CYP3A4—liver—gallbladder cancer	0.00128	0.00361	CbGeAlD
Imatinib—CYP2D6—liver—gallbladder cancer	0.00126	0.00355	CbGeAlD
Imatinib—PTGS1—lymph node—gallbladder cancer	0.00118	0.00331	CbGeAlD
Imatinib—ABCB1—liver—gallbladder cancer	0.000908	0.00256	CbGeAlD
Imatinib—ABCB1—lymph node—gallbladder cancer	0.000696	0.00196	CbGeAlD
Imatinib—LCK—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000302	0.000469	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—EGFR—gallbladder cancer	0.000301	0.000467	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—ERBB4—gallbladder cancer	0.0003	0.000466	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR—HRAS—gallbladder cancer	0.0003	0.000465	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—EGFR—gallbladder cancer	0.0003	0.000465	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—KRAS—gallbladder cancer	0.000299	0.000464	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.000298	0.000463	CbGpPWpGaD
Imatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000298	0.000461	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000297	0.000461	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—ERBB2—gallbladder cancer	0.000297	0.000461	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.000297	0.000461	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—HRAS—gallbladder cancer	0.000296	0.000459	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—EGFR—gallbladder cancer	0.000296	0.000459	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000294	0.000456	CbGpPWpGaD
Imatinib—LCK—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.000291	0.000452	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00029	0.00045	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—HRAS—gallbladder cancer	0.000286	0.000444	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000286	0.000443	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—KRAS—gallbladder cancer	0.000286	0.000443	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—KRAS—gallbladder cancer	0.000286	0.000443	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—EGFR—gallbladder cancer	0.000285	0.000442	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—KRAS—gallbladder cancer	0.000284	0.000441	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—KRAS—gallbladder cancer	0.000283	0.000439	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—NRAS—gallbladder cancer	0.000282	0.000437	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.000281	0.000435	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—HRAS—gallbladder cancer	0.00028	0.000434	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—EGFR—gallbladder cancer	0.00028	0.000434	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—KRAS—gallbladder cancer	0.000279	0.000433	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.000279	0.000432	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—HRAS—gallbladder cancer	0.000274	0.000425	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—ERBB3—gallbladder cancer	0.00027	0.000419	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—KRAS—gallbladder cancer	0.000269	0.000418	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000268	0.000416	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000268	0.000416	CbGpPWpGaD
Imatinib—KIT—Immune System—ERBB4—gallbladder cancer	0.000266	0.000413	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—KRAS—gallbladder cancer	0.000264	0.00041	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—HRAS—gallbladder cancer	0.000262	0.000406	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—HRAS—gallbladder cancer	0.000261	0.000404	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—ERBB3—gallbladder cancer	0.00026	0.000403	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—HRAS—gallbladder cancer	0.000259	0.000402	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—HRAS—gallbladder cancer	0.000258	0.0004	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—EGFR—gallbladder cancer	0.000257	0.000398	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—BCL2—gallbladder cancer	0.000255	0.000396	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—gallbladder cancer	0.000254	0.000395	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000253	0.000393	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—ERBB4—gallbladder cancer	0.000252	0.000391	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—NRAS—gallbladder cancer	0.000249	0.000385	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—ERBB2—gallbladder cancer	0.000248	0.000384	CbGpPWpGaD
Imatinib—KIT—Disease—ERBB4—gallbladder cancer	0.000246	0.000381	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—HRAS—gallbladder cancer	0.000243	0.000377	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—HRAS—gallbladder cancer	0.000243	0.000377	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000243	0.000377	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—KRAS—gallbladder cancer	0.000243	0.000376	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—HRAS—gallbladder cancer	0.000242	0.000375	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—BCL2—gallbladder cancer	0.000241	0.000374	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—HRAS—gallbladder cancer	0.000241	0.000373	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.000239	0.00037	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—ERBB2—gallbladder cancer	0.000238	0.000369	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—HRAS—gallbladder cancer	0.000238	0.000368	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ERBB4—gallbladder cancer	0.000235	0.000364	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—ERBB2—gallbladder cancer	0.000235	0.000364	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—ERBB2—gallbladder cancer	0.000233	0.000362	CbGpPWpGaD
Imatinib—PDGFRA—Disease—ERBB4—gallbladder cancer	0.000233	0.000361	CbGpPWpGaD
Imatinib—KIT—Immune System—ERBB3—gallbladder cancer	0.00023	0.000357	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.00023	0.000357	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—HRAS—gallbladder cancer	0.000229	0.000355	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—ERBB4—gallbladder cancer	0.000227	0.000352	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—EGFR—gallbladder cancer	0.000226	0.000351	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—NRAS—gallbladder cancer	0.000226	0.000351	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—ERBB2—gallbladder cancer	0.000225	0.000349	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—HRAS—gallbladder cancer	0.000225	0.000349	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.000221	0.000343	CbGpPWpGaD
Imatinib—ABL1—Immune System—ERBB4—gallbladder cancer	0.000221	0.000343	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—ERBB3—gallbladder cancer	0.000218	0.000338	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—BCL2—gallbladder cancer	0.000217	0.000337	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000215	0.000334	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.000215	0.000334	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—KRAS—gallbladder cancer	0.000214	0.000332	CbGpPWpGaD
Imatinib—KIT—Disease—ERBB3—gallbladder cancer	0.000212	0.00033	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—BCL2—gallbladder cancer	0.000212	0.000329	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—ERBB2—gallbladder cancer	0.000211	0.000328	CbGpPWpGaD
Imatinib—SLC22A2—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000211	0.000328	CbGpPWpGaD
Imatinib—PDGFRB—Disease—ERBB4—gallbladder cancer	0.00021	0.000325	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—HRAS—gallbladder cancer	0.000206	0.00032	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—EGFR—gallbladder cancer	0.000206	0.00032	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—ERBB2—gallbladder cancer	0.000206	0.000319	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ERBB3—gallbladder cancer	0.000203	0.000315	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—ERBB2—gallbladder cancer	0.000203	0.000315	CbGpPWpGaD
Imatinib—PDGFRA—Disease—ERBB3—gallbladder cancer	0.000201	0.000312	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.000198	0.000307	CbGpPWpGaD
Imatinib—SLC22A1—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000197	0.000305	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—ERBB3—gallbladder cancer	0.000196	0.000304	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—KRAS—gallbladder cancer	0.000195	0.000302	CbGpPWpGaD
Imatinib—ABL1—Immune System—ERBB3—gallbladder cancer	0.000191	0.000297	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—NRAS—gallbladder cancer	0.000188	0.000292	CbGpPWpGaD
Imatinib—LCK—Immune System—ERBB4—gallbladder cancer	0.000182	0.000283	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—HRAS—gallbladder cancer	0.000182	0.000282	CbGpPWpGaD
Imatinib—PDGFRB—Disease—ERBB3—gallbladder cancer	0.000181	0.000281	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—NRAS—gallbladder cancer	0.000181	0.000281	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—NRAS—gallbladder cancer	0.000178	0.000277	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—NRAS—gallbladder cancer	0.000177	0.000275	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—BCL2—gallbladder cancer	0.000175	0.000271	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—NRAS—gallbladder cancer	0.000174	0.00027	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ERBB4—gallbladder cancer	0.000172	0.000267	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—EGFR—gallbladder cancer	0.000172	0.000266	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—NRAS—gallbladder cancer	0.000171	0.000266	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—ERBB2—gallbladder cancer	0.00017	0.000263	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000168	0.000261	CbGpPWpGaD
Imatinib—LCK—Disease—ERBB4—gallbladder cancer	0.000168	0.000261	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—HRAS—gallbladder cancer	0.000165	0.000257	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—EGFR—gallbladder cancer	0.000165	0.000256	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ERBB4—gallbladder cancer	0.000163	0.000253	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—ERBB2—gallbladder cancer	0.000163	0.000253	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—EGFR—gallbladder cancer	0.000163	0.000252	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—KRAS—gallbladder cancer	0.000162	0.000252	CbGpPWpGaD
Imatinib—SLC22A2—Neuronal System—HRAS—gallbladder cancer	0.000162	0.000251	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—EGFR—gallbladder cancer	0.000162	0.000251	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—NRAS—gallbladder cancer	0.000161	0.000249	CbGpPWpGaD
Imatinib—LCK—Immune System—ERBB3—gallbladder cancer	0.000157	0.000244	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—NRAS—gallbladder cancer	0.000157	0.000243	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—EGFR—gallbladder cancer	0.000156	0.000242	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—KRAS—gallbladder cancer	0.000156	0.000242	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—NRAS—gallbladder cancer	0.000154	0.000239	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—KRAS—gallbladder cancer	0.000154	0.000238	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—KRAS—gallbladder cancer	0.000153	0.000237	CbGpPWpGaD
Imatinib—SLC22A1—Neuronal System—HRAS—gallbladder cancer	0.000151	0.000234	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—KRAS—gallbladder cancer	0.00015	0.000232	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000149	0.000231	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ERBB3—gallbladder cancer	0.000149	0.000231	CbGpPWpGaD
Imatinib—KIT—Immune System—BCL2—gallbladder cancer	0.000149	0.00023	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—KRAS—gallbladder cancer	0.000147	0.000229	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ERBB4—gallbladder cancer	0.000147	0.000228	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—EGFR—gallbladder cancer	0.000146	0.000227	CbGpPWpGaD
Imatinib—LCK—Disease—ERBB3—gallbladder cancer	0.000145	0.000226	CbGpPWpGaD
Imatinib—KIT—Immune System—ERBB2—gallbladder cancer	0.000144	0.000224	CbGpPWpGaD
Imatinib—LCK—Hemostasis—NRAS—gallbladder cancer	0.000143	0.000222	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—EGFR—gallbladder cancer	0.000143	0.000221	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ERBB3—gallbladder cancer	0.000141	0.000218	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000141	0.000218	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—EGFR—gallbladder cancer	0.000141	0.000218	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—BCL2—gallbladder cancer	0.000141	0.000218	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—KRAS—gallbladder cancer	0.000138	0.000215	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—HRAS—gallbladder cancer	0.000138	0.000214	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—ERBB2—gallbladder cancer	0.000137	0.000212	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—KRAS—gallbladder cancer	0.000135	0.000209	CbGpPWpGaD
Imatinib—KIT—Disease—ERBB2—gallbladder cancer	0.000133	0.000207	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—gallbladder cancer	0.000133	0.000206	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—KRAS—gallbladder cancer	0.000133	0.000206	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—HRAS—gallbladder cancer	0.000132	0.000205	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—HRAS—gallbladder cancer	0.000131	0.000202	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—HRAS—gallbladder cancer	0.00013	0.000201	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NRAS—gallbladder cancer	0.000129	0.0002	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—ERBB2—gallbladder cancer	0.000127	0.000197	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—HRAS—gallbladder cancer	0.000127	0.000197	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ERBB3—gallbladder cancer	0.000127	0.000197	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—BCL2—gallbladder cancer	0.000127	0.000196	CbGpPWpGaD
Imatinib—PDGFRA—Disease—ERBB2—gallbladder cancer	0.000126	0.000196	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—HRAS—gallbladder cancer	0.000125	0.000194	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000125	0.000194	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—NRAS—gallbladder cancer	0.000124	0.000192	CbGpPWpGaD
Imatinib—ABL1—Immune System—BCL2—gallbladder cancer	0.000123	0.000191	CbGpPWpGaD
Imatinib—LCK—Hemostasis—KRAS—gallbladder cancer	0.000123	0.000191	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—ERBB2—gallbladder cancer	0.000123	0.000191	CbGpPWpGaD
Imatinib—ABL1—Immune System—ERBB2—gallbladder cancer	0.00012	0.000186	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ERBB4—gallbladder cancer	0.000118	0.000183	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—HRAS—gallbladder cancer	0.000118	0.000182	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—EGFR—gallbladder cancer	0.000118	0.000182	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—HRAS—gallbladder cancer	0.000115	0.000178	CbGpPWpGaD
Imatinib—PDGFRB—Disease—ERBB2—gallbladder cancer	0.000114	0.000176	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—HRAS—gallbladder cancer	0.000113	0.000175	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—EGFR—gallbladder cancer	0.000113	0.000175	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—KRAS—gallbladder cancer	0.000111	0.000172	CbGpPWpGaD
Imatinib—KIT—Immune System—NRAS—gallbladder cancer	0.00011	0.00017	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—gallbladder cancer	0.00011	0.00017	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—KRAS—gallbladder cancer	0.000107	0.000165	CbGpPWpGaD
Imatinib—LCK—Hemostasis—HRAS—gallbladder cancer	0.000105	0.000163	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NRAS—gallbladder cancer	0.000104	0.000161	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ERBB3—gallbladder cancer	0.000102	0.000158	CbGpPWpGaD
Imatinib—LCK—Immune System—BCL2—gallbladder cancer	0.000102	0.000158	CbGpPWpGaD
Imatinib—KIT—Disease—NRAS—gallbladder cancer	0.000101	0.000157	CbGpPWpGaD
Imatinib—KIT—Immune System—EGFR—gallbladder cancer	0.0001	0.000155	CbGpPWpGaD
Imatinib—LCK—Immune System—ERBB2—gallbladder cancer	9.88e-05	0.000153	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NRAS—gallbladder cancer	9.69e-05	0.00015	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NRAS—gallbladder cancer	9.59e-05	0.000149	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—EGFR—gallbladder cancer	9.47e-05	0.000147	CbGpPWpGaD
Imatinib—KIT—Immune System—KRAS—gallbladder cancer	9.45e-05	0.000147	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—HRAS—gallbladder cancer	9.44e-05	0.000146	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NRAS—gallbladder cancer	9.36e-05	0.000145	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—ERBB2—gallbladder cancer	9.33e-05	0.000145	CbGpPWpGaD
Imatinib—KIT—Disease—EGFR—gallbladder cancer	9.23e-05	0.000143	CbGpPWpGaD
Imatinib—ABL1—Immune System—NRAS—gallbladder cancer	9.12e-05	0.000142	CbGpPWpGaD
Imatinib—LCK—Disease—ERBB2—gallbladder cancer	9.12e-05	0.000141	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—HRAS—gallbladder cancer	9.06e-05	0.000141	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—KRAS—gallbladder cancer	8.94e-05	0.000139	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—ERBB2—gallbladder cancer	8.83e-05	0.000137	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EGFR—gallbladder cancer	8.83e-05	0.000137	CbGpPWpGaD
Imatinib—PDGFRA—Disease—EGFR—gallbladder cancer	8.74e-05	0.000136	CbGpPWpGaD
Imatinib—KIT—Disease—KRAS—gallbladder cancer	8.72e-05	0.000135	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NRAS—gallbladder cancer	8.64e-05	0.000134	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NRAS—gallbladder cancer	8.56e-05	0.000133	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—EGFR—gallbladder cancer	8.53e-05	0.000132	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—KRAS—gallbladder cancer	8.34e-05	0.000129	CbGpPWpGaD
Imatinib—ABL1—Immune System—EGFR—gallbladder cancer	8.31e-05	0.000129	CbGpPWpGaD
Imatinib—PDGFRA—Disease—KRAS—gallbladder cancer	8.26e-05	0.000128	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—KRAS—gallbladder cancer	8.06e-05	0.000125	CbGpPWpGaD
Imatinib—KIT—Immune System—HRAS—gallbladder cancer	8.03e-05	0.000125	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—ERBB2—gallbladder cancer	7.96e-05	0.000123	CbGpPWpGaD
Imatinib—PDGFRB—Disease—EGFR—gallbladder cancer	7.88e-05	0.000122	CbGpPWpGaD
Imatinib—ABL1—Immune System—KRAS—gallbladder cancer	7.85e-05	0.000122	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HRAS—gallbladder cancer	7.6e-05	0.000118	CbGpPWpGaD
Imatinib—LCK—Immune System—NRAS—gallbladder cancer	7.51e-05	0.000117	CbGpPWpGaD
Imatinib—PDGFRB—Disease—KRAS—gallbladder cancer	7.44e-05	0.000115	CbGpPWpGaD
Imatinib—KIT—Disease—HRAS—gallbladder cancer	7.42e-05	0.000115	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—gallbladder cancer	7.41e-05	0.000115	CbGpPWpGaD
Imatinib—ALB—Hemostasis—KRAS—gallbladder cancer	7.37e-05	0.000114	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NRAS—gallbladder cancer	7.1e-05	0.00011	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HRAS—gallbladder cancer	7.09e-05	0.00011	CbGpPWpGaD
Imatinib—PDGFRA—Disease—HRAS—gallbladder cancer	7.02e-05	0.000109	CbGpPWpGaD
Imatinib—LCK—Disease—NRAS—gallbladder cancer	6.94e-05	0.000108	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HRAS—gallbladder cancer	6.85e-05	0.000106	CbGpPWpGaD
Imatinib—LCK—Immune System—EGFR—gallbladder cancer	6.85e-05	0.000106	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NRAS—gallbladder cancer	6.72e-05	0.000104	CbGpPWpGaD
Imatinib—ABL1—Immune System—HRAS—gallbladder cancer	6.67e-05	0.000104	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—gallbladder cancer	6.55e-05	0.000102	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EGFR—gallbladder cancer	6.47e-05	0.0001	CbGpPWpGaD
Imatinib—LCK—Immune System—KRAS—gallbladder cancer	6.47e-05	0.0001	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—ERBB2—gallbladder cancer	6.38e-05	9.9e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—HRAS—gallbladder cancer	6.32e-05	9.81e-05	CbGpPWpGaD
Imatinib—LCK—Disease—EGFR—gallbladder cancer	6.32e-05	9.8e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—HRAS—gallbladder cancer	6.27e-05	9.72e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EGFR—gallbladder cancer	6.12e-05	9.49e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—KRAS—gallbladder cancer	6.11e-05	9.47e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NRAS—gallbladder cancer	6.05e-05	9.39e-05	CbGpPWpGaD
Imatinib—LCK—Disease—KRAS—gallbladder cancer	5.97e-05	9.26e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—KRAS—gallbladder cancer	5.78e-05	8.97e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EGFR—gallbladder cancer	5.51e-05	8.55e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—HRAS—gallbladder cancer	5.5e-05	8.52e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—gallbladder cancer	5.43e-05	8.42e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—KRAS—gallbladder cancer	5.21e-05	8.08e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HRAS—gallbladder cancer	5.19e-05	8.05e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—gallbladder cancer	5.14e-05	7.97e-05	CbGpPWpGaD
Imatinib—LCK—Disease—HRAS—gallbladder cancer	5.07e-05	7.87e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HRAS—gallbladder cancer	4.92e-05	7.62e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NRAS—gallbladder cancer	4.86e-05	7.53e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—gallbladder cancer	4.63e-05	7.18e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HRAS—gallbladder cancer	4.43e-05	6.87e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EGFR—gallbladder cancer	4.43e-05	6.86e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—KRAS—gallbladder cancer	4.18e-05	6.48e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—gallbladder cancer	3.72e-05	5.76e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HRAS—gallbladder cancer	3.55e-05	5.51e-05	CbGpPWpGaD
